The
division of Hematology and Oncology consists of three full-time
faculty and one oncology nurse, who are committed to providing "state
of the art" care to the community. Inpatient oncology services
are currently provided throughout the Kennedy Health System and
at two divisions of the Virtua-West Jersey Health System. Outpatient
services are provided at three of the Department's ambulatory sites.
Along with clinical excellence,
the division has a committment to high quality education. Research
faculty participate in the teaching of medical students and residents.
A fellowship in Oncology has been approved and will begin training
future oncologists in the next academic year. The division is a
participant in the Clinical Trials Support Unit of the National
Cancer Institute, as well as members of the Cancer Institute of
New Jersey Eastern Cooperative Oncology Group. The expansion of
the division was intended largely to participate in the development
of UMDNJ-SOM's Cancer Institute. As part of the strategic plan,
the Department of Medicine in the next several years will be playing
an integral role in the development of UMDNJ-SOM's Center of Excellence
in Cancer. The center will expand the school's cancer program enabling
it to become a premier location for the latest in cancer care in
the region.
The division offers a multidisciplinary staff
providing a coordinated approach to treatment to best meet the
needs of each patient. Thus, tumor specific programs have been
organized to ensure that patients receive state of the art care.
These include:
- The Breast Cancer Evaluation program which offers
education, risk assessment and evaluation for individuals with
a family
history of cancer, as well as those with established or possible
breast cancer.
- The Gastrointestinal Assessment program which addresses colorectal,
gastric and pancreatic cancers which are the most common gastrointestinal
cancers among americans. This comprehensive program will assure
that "state of the art" approaches for patients with
gastrointestinal cancers are available.
- A Genitourinary program which addresses cancers of the kidney,
ureter, bladder, prostate, urethra, penis, adrenal and testicles.
It utilizes a multidisciplinary approach offering the latest
chemotherapeutic and immunotherapy treatment options.
A team approach to care consisting of a medical
oncologist, surgeon, radiation oncologist and nurse will assure
comprehensive, competent and holistic care. The division is committed
to the highest quality of care for its patients.
|
